An important pathway involving YY1 is the NF-κB/YY1/ RKIP regulatory axis, which has been shown to significantly contribute to tumor cell resistance against both chemotherapy and immunotherapy-induced cytotoxicity [47,48,49]. The gene discussed is NFKB1; the disease is neoplasm.